Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

JAMA

Volumn 295, Issue 14, 2006, Pages 1668-1674

  Poehling, Katherine A ^a   Talbot, Thomas R ^a   Griffin, Marie R ^a   Craig, Allen S ^b   Whitney, Cynthia G ^c   Zell, Elizabeth ^c   Lexau, Catherine A ^d   Thomas, Ann R ^e   Harrison, Lee H ^f,g   Reingold, Arthur L ^h   Hadler, James L ⁱ   Farley, Monica M ^j   Anderson, Bridget J ^k   Schaffner, William ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d MINNESOTA DEPARTMENT OF HEALTH   (United States)

^e Office of Disease Prevention and Epidemiology   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Infectious Diseases Section   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; VACCINE;

ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; FEMALE; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; OSTEOMYELITIS; PNEUMONIA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; ANTIBIOTIC RESISTANCE; CLASSIFICATION; DRUG EFFECT; HEALTH SURVEY; HERD IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; NEWBORN; PROSPECTIVE STUDY; SEROTYPING; UNITED STATES;

DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMMUNITY, HERD; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINES, CONJUGATE;

EID: 33645741222     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.14.1668     Document Type: Article

References (36)

1. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2000;49(RR-9):1-35.
2. American Academy of Pediatrics; Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
3. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
4. Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004;39:641-648.
5. Gomez M, Alter S, Kumar ML, Murphy S, Rathore MH. Neonatal Streptococcus pneumoniae infection: case reports and review of the literature. Pediatr Infect Dis J. 1999;18:1014-1018.
6. Hoffman JA, Mason EO, Schutze GE, et al. Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003;112:1095-1102.
7. Simpson JM, Patel JS, Ispahani P. Streptococcus pneumoniae invasive disease in the neonatal period: an increasing problem? Eur J Pediatr. 1995;154:563-566.
8. Sadow KB, Derr R, Teach SJ. Bacterial infections in infants 60 days and younger: epidemiology, resistance, and implications for treatment. Arch Pediatr Adolesc Med. 1999;153:611-614.
9. Pavis A, Cortey A, Lozniewski A, Weber M, Vert P. Early-onset septicemia in a newborn due to a penicillin resistant pneumococcus probably transmitted during delivery. Eur J Clin Microbiol Infect Dis. 1995;14:68-69.
10. McDonald LC, Bryant K, Snyder J. Peripartum transmission of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol. 2003;41:2258-2260.
11. Bradley JS, Kaplan SL, Tan TQ, et al. Pediatric pneumococcal bone and joint infections: the Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998;102:1376-1382.
12. Dagan R, Fraser D, Roitman M, et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenza b. Vaccine. 1999;17:134-141.
13. Schuchat A, Hilger T, Zell E, et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Emerg Infect Dis. 2001;7:92-99.
14. Center for Health Statistics, Office of Health Information and Research. California Live Birth Data, 1997-2003. Available at: http://www.dhs.ca.gov/hisp/ chs/OHIR. Accessed August 1, 2005.
15. Connecticut Department of Public Health. Connecticut Live Birth Data, 1997-2001. Available at: http://www.dph.state.ct.us. Accessed August 1, 2005.
16. Georgia Division of Public Health. Georgia Live Birth Data, 1997-2003. Available at: http://health.state.ga.us/programs/ohip/birthdeath.asp. Accessed August 1, 2005.
17. Vital Statistics Administration. Maryland Live Birth Data, 1997-2003. Available at: http://mdpublichealth.org/vsa/html/reports.html. Accessed August 1, 2005.
18. Minnesota Department of Health. Minnesota Live Birth Data, 1997-2003. Available at: http://www.health.state.mn.us. Accessed August 1, 2005.
19. Vital Statistics of New York State. New York Live Birth Data, 1997-2003. Available at: http://www.health.state.ny.us/nysdoh/vital_statistics. Accessed August 1, 2005.
20. State of Oregon: Public Health. Oregon Live Birth Data, 1997-2003. Available at: http://www.ohd.hr.state.or.us. Accessed August 1, 2005.
21. Tennessee Department of Health. Tennessee Live Birth Data, 1997-2003. Available at: http://www2.state.tn.us/health/statistics. Accessed August 1, 2005.
22. National Vital Statistics Reports. Conneticut Live Birth Data, 2002-2003. Available at: http://www.cdc.gov/nchs/nvss.htm. Accessed August 1, 2005.
23. Freed GL, Davis MM, Andreae MC, Bass S, Weinblatt H. Reimbursement for Prevnar: a modern-day version of Hercules and the Hydra. Pediatrics. 2002;110:399-400.
24. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. Vol 22. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2002. NCCLS document M100-S12.
25. Rubin DB, Schenker N. Logit-based interval estimation for binomial data using the Jeffrey's Prior. Sociol Methodol. 1987;17:131-144.
26. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004;291:2197-2203.
27. Dagan R, Givon-Lavi N, Fraser D, Lipsitch M, Siber GR, Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis. 2005;192:367-376.
28. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:690-695.
29. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance: Reports and Findings. Available at: http://www.cdc.gov/ncidod/ dbmd/abcs.reports.htm. Accessed February 8, 2006.
30. Hausdorff WP. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr. 2002;161:S135-S139.
31. O'Brien KL, Santosham M. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am J Epidemiol. 2004;159:634-644.
32. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevenition in the conjugate vaccine era. JAMA. 2001;285:1729-1735.
33. Talbot TR, Poehling KA, Hartert TV, et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004;23:726-731.
34. Huang SS, Platt R, Rigas-Shiman SC, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachuetts communities, 2001 and 2004. Pediatrics. 2005; 116:e408-e413. doi:10.1542/peds.2004-2338. Accessed on November 8, 2005.
35. McEllistrem MC, Adams JM, Shutt K, et al. Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001. Emerg Infect Dis. 2005;11:969-972.
36. Centers for Disease Control and Prevention. National Immunization Survey, 2001-2004. Available at: http://www.cdc.gov/nip/coverage/#NIS. Accessed August 3, 2005.